Tags
Results for: Hourigan Lab
-
Article Item
Blood cancer researcher aims to stop the disease before it starts , articleSushree Sahoo, assistant professor in the Fralin Biomedical Research Institute’s Cancer Research Center — D.C., studies the hidden window between genetic mutation and cancer, seeking ways to intervene before disease ever develops.
Date: Apr 13, 2026 - -
Article Item
Graduate course brings federal health experts into the classroom , articleA course offered to translational biology, medicine, and health students in Washington, D.C., this spring marks a new chapter for the graduate program.
Date: Apr 13, 2026 - -
Video Item
TBMH course gives graduate students hands-on laboratory learning , videoFor the first time in Washington, D.C., graduate students can take a course in Translational Biology, Medicine, and Health (TBMH). Taught by Laura Dillon, research associate professor at Virginia Tech’s Fralin Biomedical Research Institute, the course leverages the university’s proximity to federal research agencies and combines expert-led lectures, hands-on laboratory and bioinformatics training, and case-based learning. Through workshops, sequencing experiments, and simulated patient cases, students learn how cancer genomics informs diagnosis, prognosis, therapy development, and regulatory decision-making, preparing them for careers across academia, industry, and government.
Date: Apr 13, 2026 - -
Article Item
Researchers drill down on genetics to guide treatment for leukemia patients , articleCancer researchers are making strides in efforts to use genetic profiles to develop a better understanding of how people respond to treatment for a rare but aggressive blood cancer.
Date: Mar 06, 2026 - -
Article Item
Seeing brain tumors through a neuroscience lens , articleCancer researcher Qi Ye investigates how brain tumors can hijack other cell systems to promote their own progression.
Date: Feb 19, 2026 - -
Article Item
Researcher advances new approach to blood cancer treatment , articleChristopher Hourigan, a physician-scientist, is leading nationwide efforts to develop advanced techniques to better identify residual disease and tailor treatment for each patient with acute myeloid leukemia, a highly fatal blood cancer.
Date: Sep 30, 2025 - -
Article Item
Immunotherapy for leukemia may change the bone marrow environment, cancer researchers find , articleScientists studying a hard-to-treat form of blood cancer called acute myeloid leukemia have found that a type of treatment — immunotherapy — may help change the environment where cancer cells live, possibly helping the immune system respond more effectively.
Date: Jul 31, 2025 - -
Article Item
‘Every time we wait, we lose someone who might have made it’ , articleFor every careful step forward in cancer research, there is a patient waiting — a family holding its breath in the middle of the night. That reality was clear at the Fralin Biomedical Research Institute’s Cancer Research Symposium.
Date: Jun 27, 2025 - -
Video ItemCancer Researchers Spurred to Move Faster at the Cancer Research Symposium , video
For every careful step forward in cancer research, there is a patient waiting — a family holding its breath in the middle of the night. That reality was clear at the Fralin Biomedical Research Institute’s Cancer Research Symposium in Roanoke. The annual event, organized this year by the Fralin Biomedical Research Institute at VTC Cancer Research Center in Roanoke, was created to bring together researchers — including faculty, clinicians, and students — who are united by a passion to understand cancer, improve treatments, and develop cures.
Date: Jun 25, 2025 - -
Article Item
Graduate students share work at inaugural research showcase at Academic Building One , articleGraduate students from programs across the greater Washington, D.C,. metro area shared their work at the Graduate Education Week Research Showcase in Alexandria.
Date: Apr 03, 2025 - -
Article Item
New Virginia Tech cancer researcher seeks to understand and predict deadly tumor metastasis , articleShenglin Mei, the newest principal investigator of the Fralin Biomedical Research Institute Cancer Research Center in Washington, D.C., applies computational biology, genetics, and immunology to study cancer’s spread away from the primary tumor.
Date: Dec 17, 2024 - -
Article Item
Virginia Tech, Children’s National Hospital, and industry experts explore the impact of AI on health care , articleWhile exploring the potential of artificial intelligence, old fashioned networking and human relationships held the floor.
Date: Sep 24, 2024 - -
Article Item
Federal leaders take center stage at Engineering Cancer Solutions mini-symposium , articleThree federal leaders – one each from the White House, the National Cancer Institute, and the Food and Drug Administration – mixed with Virginia Tech students, early career researchers, and leadership at the Fralin Biomedical Research Institute Cancer Research Center in Washington, D.C.
Date: Jul 12, 2024 - -
Article Item
Testing for residual cancer cells before blood cell transplant therapy is important and practical, new study finds , articlePatients in remission after battling blood cancer are likely to have better outcomes if no trace of the cancer is detectable before the patients receive donor blood cells. The finding in JAMA Oncology emphasizes the importance of testing for lingering cancer cells in the body after people receive apparently successful chemotherapy treatment.
Date: May 02, 2024 - -
Video ItemEminent cancer physician-scientist joins Virginia Tech to lead research in Washington, D.C. , video
Christopher Hourigan will spearhead innovative cancer solutions at the Fralin Biomedical Research Institute Cancer Research Center in the nation's capital.
Date: Apr 10, 2024 - -
Article Item
Virginia Tech professor to be inducted into prestigious American Society for Clinical Investigation , articleChristopher Hourigan, director of the Cancer Research Center – D.C., has been inducted into the American Society for Clinical Investigation, a historic membership for a faculty member of Virginia Tech.
Date: Apr 04, 2024 - -
Article Item
Eminent cancer physician-scientist joins Virginia Tech to lead research in Washington, D.C. , articleA National Institutes of Health senior investigator who studies and treats blood cancer, Christopher Hourigan is joining Virginia Tech to lead cancer research at the Fralin Biomedical Research Institute in Washington, D.C.
Date: Apr 01, 2024 -